Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Draegerwerk AG KGaADGWPF 72 Debt-to-Equity is 0.23 as of Jun. 2026, which is 10% above its 10-year median of 0.21. GuruFocus rates DGWPF with a GF Score™ of 72/100 and a GF Value™ of $61.11 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 699 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks better than 50.21% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Draegerwerk AG KGaA's Debt-to-Equity or its related term are showing as below:
DGWPF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14 Med: 0.21 Max: 0.38
Current: 0.23
During the past 13 years, the highest Debt-to-Equity Ratio of Draegerwerk AG KGaA was 0.38. The lowest was 0.14. And the median was 0.21.
DGWPF's Debt-to-Equity is ranked better than 50.21% of 699
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs DGWPF: 0.23
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Draegerwerk AG KGaA Debt-to-Equity Related Terms
Draegerwerk AG KGaA Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Draegerwerk AG KGaA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (DGWPF) has a Debt-to-Equity of 0.23 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Draegerwerk AG KGaA and its competitors. This is 10% above median its historical median of 0.21. Over the past decade, Draegerwerk AG KGaA's Debt-to-Equity has ranged from 0.14 to 0.38. According to the industry distribution chart, Draegerwerk AG KGaA ranks #348 out of 699 companies in the Medical Devices & Instruments industry, placing it in the top 49.8%.
Is Draegerwerk AG KGaA's Debt-to-Equity too high?
Draegerwerk AG KGaA's current Debt-to-Equity of 0.23 is 10% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 0.38. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Draegerwerk AG KGaA's value of 0.23 is 0% at this industry median. Based on the distribution chart, Draegerwerk AG KGaA ranks #348 out of 699 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Draegerwerk AG KGaA has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #348 out of 699 companies for Debt-to-Equity. This puts Draegerwerk AG KGaA in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Draegerwerk AG KGaA's value of 0.23 is 0% at this benchmark. Historically, Draegerwerk AG KGaA's own Debt-to-Equity has ranged from 0.14 to 0.38 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.23, Draegerwerk AG KGaA has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current Debt-to-Equity of 0.23 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Draegerwerk AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current Debt-to-Equity is 0.23, which is 10% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (DGWPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.11, compared to a current price of $93.00 — trading 52.2% above its estimated fair value. The current Debt-to-Equity is 0.23, which is 10% above median its 10-year median of 0.21 and 0% at the Medical Devices & Instruments industry median of 0.23. Draegerwerk AG KGaA's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Draegerwerk AG KGaA (DGWPF), the current Debt-to-Equity is 0.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (DGWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of $93.00 is trading 52.2% above its estimated GF Value™ of $61.11.
GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.
Key valuation signals for DGWPF:
Debt-to-Equity: 0.23 (10% above median its 10-year median of 0.21)
GF Value™: $61.11 vs. price of $93.00 (52.2% above fair value)
Industry Position: 0% at the Medical Devices & Instruments median (#348 of 699)
No single metric tells the full story. See the DGWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
72GF Score
Get the complete analysis for DGWPF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DGWPF has been successfully added to your 
